ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Organon Pharma (UK) Limited

Organon Pharma (UK) Limited is an active company incorporated on 25 September 1964 with the registered office located in Cramlington, Northumberland. Organon Pharma (UK) Limited was registered 61 years ago.
Status
Active
Active since incorporation
Company No
00820771
Private limited company
Age
61 years
Incorporated 25 September 1964
Size
Large
Turnover is over £54M
Balance sheet is over £27M
Over 250 employees
Confirmation
Submitted
Dated 10 July 2025 (4 months ago)
Next confirmation dated 10 July 2026
Due by 24 July 2026 (8 months remaining)
Last change occurred 1 year 4 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (10 months remaining)
Address
Organon Pharma (Uk) Limited
Shotton Lane
Cramlington
NE23 3JU
United Kingdom
Address changed on 21 Jun 2024 (1 year 4 months ago)
Previous address was Organon Pharma (Uk) Limited Shotton Lane Cramlington England and Wales NE23 3JU United Kingdom
Telephone
01992467272
Email
Available in Endole App
Website
People
Officers
10
Shareholders
1
Controllers (PSC)
1
Director • Director • Finance Lead • French • Lives in France • Born in Jan 1981
Director • Director • Director Business Practices & Data Privacy • British • Lives in UK • Born in Aug 1976
Director • British • Lives in UK • Born in Oct 1980
Director • Financial Director • Belgian • Lives in Belgium • Born in Feb 1978
Director • Marketing Director • British • Lives in UK • Born in May 1978
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Dashtag
Josef Ralph Laskowski, Michael Whale, and 4 more are mutual people.
Active
Dermavant Holdings Limited
Anne Bitzer and Nicola Barr are mutual people.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
Unreported
Decreased by £11.62M (-100%)
Turnover
£153.01M
Increased by £14.1M (+10%)
Employees
713
Increased by 38 (+6%)
Total Assets
£209.1M
Increased by £22.52M (+12%)
Total Liabilities
-£104.14M
Increased by £22.6M (+28%)
Net Assets
£104.96M
Decreased by £76K (-0%)
Debt Ratio (%)
50%
Increased by 6.1% (+14%)
Latest Activity
Full Accounts Submitted
1 Month Ago on 3 Oct 2025
Nicola Barr Appointed
2 Months Ago on 1 Sep 2025
Sofia Raquel Paulos Ferreira Alves Da Silva Appointed
2 Months Ago on 1 Sep 2025
Anne Bitzer Appointed
2 Months Ago on 1 Sep 2025
Isabel Vandenberk Resigned
3 Months Ago on 31 Jul 2025
Confirmation Submitted
4 Months Ago on 10 Jul 2025
Sandy Lindsey Resigned
5 Months Ago on 30 May 2025
Full Accounts Submitted
1 Year 1 Month Ago on 30 Sep 2024
Confirmation Submitted
1 Year 4 Months Ago on 10 Jul 2024
Organon & Co., Inc. (PSC) Details Changed
4 Years Ago on 3 Jun 2021
Get Credit Report
Discover Organon Pharma (UK) Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Full accounts made up to 31 December 2024
Submitted on 3 Oct 2025
Appointment of Nicola Barr as a director on 1 September 2025
Submitted on 25 Sep 2025
Appointment of Anne Bitzer as a director on 1 September 2025
Submitted on 10 Sep 2025
Appointment of Sofia Raquel Paulos Ferreira Alves Da Silva as a director on 1 September 2025
Submitted on 10 Sep 2025
Termination of appointment of Isabel Vandenberk as a director on 31 July 2025
Submitted on 19 Aug 2025
Confirmation statement made on 10 July 2025 with no updates
Submitted on 10 Jul 2025
Termination of appointment of Sandy Lindsey as a director on 30 May 2025
Submitted on 26 Jun 2025
Change of details for Organon & Co., Inc. as a person with significant control on 3 June 2021
Submitted on 5 Dec 2024
Full accounts made up to 31 December 2023
Submitted on 30 Sep 2024
Confirmation statement made on 10 July 2024 with updates
Submitted on 10 Jul 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year